![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Liver Diseases |
Free Subscription
1 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Diseases is free of charge.
Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low
HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of
Hepatic Decompensation?
Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
PubMed
Gastroenterology/Hepatology: What You May Have Missed in 2023.
Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
PubMed
Abstract available
PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration.
Biochem Biophys Res Commun. 2024;712-713:149958.
PubMed
Abstract available
Impact of hepatic inflammation and fibrosis on the recurrence and long-term
survival of hepatitis B virus-related hepatocellular carcinoma patients after
hepatectomy.
BMC Cancer. 2024;24:475.
PubMed
Abstract available
Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma
via the miR-375-3P/SLC7A11 axis.
BMC Cancer. 2024;24:496.
PubMed
Abstract available
ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental
validation.
BMC Cancer. 2024;24:452.
PubMed
Abstract available
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut
microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
BMC Cancer. 2024;24:472.
PubMed
Abstract available
HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients
with high-risk advanced HCC: a real-world study.
BMC Cancer. 2024;24:480.
PubMed
Abstract available
Stereotactic ablative brachytherapy versus percutaneous microwave ablation as
salvage treatments for lung oligometastasis from colorectal cancer.
BMC Cancer. 2024;24:481.
PubMed
Abstract available
Interpretable machine learning-based clinical prediction model for predicting
lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
BMC Gastroenterol. 2024;24:137.
PubMed
Abstract available
Impact of donor characteristics on hepatocellular carcinoma recurrence after
liver transplantation.
Br J Surg. 2024;111:znae080.
PubMed
Long-term outcomes of ruptured hepatocellular carcinoma: international
multicentre study.
Br J Surg. 2024;111:znae093.
PubMed
Global phase 3 results show that bevacizumab with immunotherapy has activity in
liver cancer.
Cancer. 2024;130:1547-1548.
PubMed
Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote
colorectal cancer liver metastasis.
Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2123.
PubMed
Abstract available
Organizational and Implementation Factors Associated with Cirrhosis Care in the
Veterans Health Administration.
Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
PubMed
Abstract available
Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver
Disease-Value Added or Work in Progress?
Dig Dis Sci. 2024;69:1093-1095.
PubMed
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic
Dysfunction-Associated Steatotic Liver Disease.
Dig Dis Sci. 2024;69:1444-1453.
PubMed
Abstract available
Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating
Coiled-Coil Domain-Containing Protein 178.
Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-024-08312.
PubMed
Abstract available
Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical
Presentations.
Dig Dis Sci. 2024;69:1479-1487.
PubMed
Abstract available
Insulin Resistance/Sensitivity Measures as Screening Indicators of
Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
Dig Dis Sci. 2024;69:1430-1443.
PubMed
Abstract available
Detection of residual stones by peroral direct cholangioscopy in patients with
intrahepatic stones after hepaticojejunostomy: A prospective study (with video).
Gastrointest Endosc. 2024 Apr 15:S0016-5107(24)00234.
PubMed
Abstract available
British Society of Gastroenterology guidelines for the management of
hepatocellular carcinoma in adults.
Gut. 2024 Apr 16:gutjnl-2023-331695. doi: 10.1136/gutjnl-2023-331695.
PubMed
Abstract available
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab
le, gut-restricted adsorbent in models and patients with cirrhosis.
Gut. 2024 Apr 15:gutjnl-2023-330699. doi: 10.1136/gutjnl-2023-330699.
PubMed
Abstract available
Genetic landscape of pediatric acute liver failure of indeterminate origin.
Hepatology. 2024;79:1075-1087.
PubMed
Abstract available
Association between hepatitis delta virus with liver morbidity and mortality: A
systematic literature review and meta-analysis.
Hepatology. 2023 Oct 23. doi: 10.1097/HEP.0000000000000642.
PubMed
Abstract available
Validation of AGA clinical care pathway and AASLD practice guidance for
nonalcoholic fatty liver disease in a prospective cohort of patients with type 2
diabetes.
Hepatology. 2024;79:1098-1106.
PubMed
Abstract available
Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive
review.
Hepatology. 2024;79:1141-1157.
PubMed
Abstract available
Spatial metabolomics and its application in the liver.
Hepatology. 2024;79:1158-1179.
PubMed
Abstract available
Clonal hematopoiesis of indeterminate potential and risk of hepatocellular
carcinoma: New kids on the block.
Hepatology. 2024 Apr 19. doi: 10.1097/HEP.0000000000000898.
PubMed
Machine learning-based plasma metabolomic profiles for predicting long-term
complications of cirrhosis.
Hepatology. 2024 Apr 17. doi: 10.1097/HEP.0000000000000879.
PubMed
Abstract available
Erratum: Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a
theranostic target in human hepatocellular carcinoma.
Hepatology. 2024;79:E150-E151.
PubMed
ER stress signaling at the interphase between MASH and hepatocellular carcinoma.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000893.
PubMed
Abstract available
Letter to the Editor: On the use of non-selective beta blockers in cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000888.
PubMed
Reply: On the use of non-selective beta blockers in cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000889.
PubMed
Innovations in Healthcare Delivery for Patients with Cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000892.
PubMed
Metabolic dysfunction-associated steatotic liver disease: Update and impact of
new nomenclature on the American Association for the Study of Liver Diseases
practice guidance on nonalcoholic fatty liver disease.
Hepatology. 2024;79:1212-1219.
PubMed
Abstract available
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Hepatology. 2024;79:E130-E131.
PubMed
Letter to the Editor: Concerns regarding the use of fatty liver index in studies
of lean NAFLD.
Hepatology. 2024;79:E129.
PubMed
HDV RNA and liver disease progression: What do we know?
Hepatology. 2024;79:983-985.
PubMed
Reply: Improving access to transient elastography data for Real-World Prognostic
Applications in primary biliary cholangitis.
Hepatology. 2023 Dec 27. doi: 10.1097/HEP.0000000000000746.
PubMed
Letter to the Editor: Improving access to transient elastography data for
real-world prognostic applications in primary biliary cholangitis.
Hepatology. 2023 Dec 27. doi: 10.1097/HEP.0000000000000744.
PubMed
Reply: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?
Hepatology. 2024;79:E141-E143.
PubMed
Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1
subclass?
Hepatology. 2024;79:E140.
PubMed
Letter to the Editor: Diagnostic accuracy of AGILE 3+ score for advanced fibrosis
in patients with NAFLD: A systematic review and meta-analysis.
Hepatology. 2024;79:E144-E145.
PubMed
Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients
with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Hepatology. 2024;79:E146-E147.
PubMed
Effects of trientine and penicillamine on intestinal copper uptake: A mechanistic
64 Cu PET/CT study in healthy humans.
Hepatology. 2024;79:1065-1074.
PubMed
Abstract available
Incorporation of genetic testing into the diagnostic algorithms of PALF: The time
is now.
Hepatology. 2024;79:970-972.
PubMed
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with
NAFLD: A systematic review and meta-analysis.
Hepatology. 2024;79:1107-1116.
PubMed
Abstract available
Longitudinal changes in bone mineral density may be associated with long-term
survival in patients with cirrhosis: A proof of concept of study.
Indian J Gastroenterol. 2024 Apr 15. doi: 10.1007/s12664-023-01504.
PubMed
Abstract available
Impact of self-reported ancestry on the epidemiology of hepatocellular carcinoma.
J Gastroenterol Hepatol. 2024 Apr 13. doi: 10.1111/jgh.16578.
PubMed
DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters
mitochondrial fitness in fibrolamellar carcinoma.
PLoS Genet. 2024;20:e1011216.
PubMed
Abstract available
Serum proteomic profiling of patients with compensated advanced chronic liver
disease with and without clinically significant portal hypertension.
PLoS One. 2024;19:e0301416.
PubMed
Abstract available
Identification of differentially expressed mRNA/lncRNA modules in acutely
regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.
PLoS One. 2024;19:e0301663.
PubMed
Abstract available
Increased risk of chronic kidney disease and mortality in a cohort of people
diagnosed with metabolic dysfunction associated steatotic liver disease with
hepatic fibrosis.
PLoS One. 2024;19:e0299507.
PubMed
Abstract available
Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases:
A multicenter cross sectional-study.
PLoS One. 2024;19:e0290632.
PubMed
Abstract available
Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating
Musashi-2 protein.
PLoS One. 2024;19:e0299920.
PubMed
Abstract available
Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of
NAFLD.
PLoS One. 2024;19:e0297572.
PubMed
Abstract available
Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress,
hepatic lipodystrophy, and systemic insulin resistance.
Proc Natl Acad Sci U S A. 2024;121:e2320934121.
PubMed
Abstract available
Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
Radiology. 2024;311:e232426.
PubMed
Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care
Setting.
Semin Liver Dis. 2024;44:23-34.
PubMed
Abstract available
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated
Steatotic Liver Disease.
Semin Liver Dis. 2024;44:54-68.
PubMed
Abstract available
UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
Semin Liver Dis. 2024;44:1-22.
PubMed
Abstract available
GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
Semin Liver Dis. 2024;44:99-114.
PubMed
Abstract available
Gestational and Developmental Contributors of Pediatric MASLD.
Semin Liver Dis. 2024;44:43-53.
PubMed
Abstract available
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic
Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and
Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
Semin Liver Dis. 2024;44:35-42.
PubMed
Abstract available
Is There a Safe Alcohol Consumption Limit for the General Population and in
Patients with Liver Disease?
Semin Liver Dis. 2024;44:69-78.
PubMed
Abstract available
Thank you for your interest in scientific medicine.